Arbor Trust Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Arbor Trust Wealth Advisors's PFE Position: Q2 2025 in Review
Arbor Trust Wealth Advisors sold out of Pfizer (PFE) in Q2 2025, closing a stake of 11,343 shares — an estimated $287K sold.
Arbor Trust Wealth Advisors first reported a position in PFE in Q4 2019 and held it in 22 quarters. The position peaked at $911K in Q4 2022. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Arbor Trust Wealth Advisors reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Arbor Trust Wealth Advisors sold 11,343 Pfizer shares in Q2 2025, an estimated $287K.
- Arbor Trust Wealth Advisors first reported a position in Pfizer in Q4 2019 and held it in 22 quarters.
- Arbor Trust Wealth Advisors's Pfizer position peaked at $911K in Q4 2022.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Arbor Trust Wealth Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.